Nuclease News and Research

RSS
IDT to demonstrate CRISPR expertise at European-focused events

IDT to demonstrate CRISPR expertise at European-focused events

Researchers deplete key protein for DNA replication using protein degradation system

Researchers deplete key protein for DNA replication using protein degradation system

Gene therapy approach could help treat mitochondrial diseases

Gene therapy approach could help treat mitochondrial diseases

Using CRISPR-Cas9 genome editing to correct mutation responsible for sickle cell disease

Using CRISPR-Cas9 genome editing to correct mutation responsible for sickle cell disease

AMSBIO introduces new, powerful CRISPR/Cas9 gene editing kits

AMSBIO introduces new, powerful CRISPR/Cas9 gene editing kits

New RNA deletion tool could help create drugs that correct genetic diseases

New RNA deletion tool could help create drugs that correct genetic diseases

LogicBio team to present data on preclinical effectiveness of GeneRide platform

LogicBio team to present data on preclinical effectiveness of GeneRide platform

Scientists uncover new answers to cell aging in children with rare, fatal disease

Scientists uncover new answers to cell aging in children with rare, fatal disease

Benson Hill Biosystems granted patent for novel genome editing system

Benson Hill Biosystems granted patent for novel genome editing system

Scientists develop ultrasound-propelled nanomotors for active delivery of Cas9-sgRNA complex

Scientists develop ultrasound-propelled nanomotors for active delivery of Cas9-sgRNA complex

Sangamo and Pfizer partner for development of new zinc finger protein gene therapy to treat ALS

Sangamo and Pfizer partner for development of new zinc finger protein gene therapy to treat ALS

Study focuses on improving pharmacokinetic properties of therapeutic aptamers

Study focuses on improving pharmacokinetic properties of therapeutic aptamers

Researchers visualize mechanism of CRISPR-Cas9 genetic-engineering technique

Researchers visualize mechanism of CRISPR-Cas9 genetic-engineering technique

UTSW receives $34 million CPRIT award for cancer research and faculty recruitment

UTSW receives $34 million CPRIT award for cancer research and faculty recruitment

IDT introduces first Cas9 enzyme variant that greatly reduces off-target effects in CRISPR genome editing

IDT introduces first Cas9 enzyme variant that greatly reduces off-target effects in CRISPR genome editing

Cellectis wins European patent for CRISPR use in T-cells

Cellectis wins European patent for CRISPR use in T-cells

CRISPR may not be as foolproof as earlier believed – gene editing tech leads to unwanted mutations

CRISPR may not be as foolproof as earlier believed – gene editing tech leads to unwanted mutations

Study discovers new role for DNA2 enzyme in repair process

Study discovers new role for DNA2 enzyme in repair process

IDT offers cost-effective and most complete spectrum of CRISPR genome editing systems

IDT offers cost-effective and most complete spectrum of CRISPR genome editing systems

Researchers uncover first ‘off-switches’ for better control of CRISPR/Cas9 gene editing

Researchers uncover first ‘off-switches’ for better control of CRISPR/Cas9 gene editing